CVS Health Corp. (CVS)

62.65
NYSE : Retail Trade
Prev Close 61.28
Day Low/High 61.00 / 62.73
52 Wk Low/High 52.04 / 77.03
Avg Volume 7.61M
Exchange NYSE
Shares Outstanding 1.31B
Market Cap 83.55B
EPS 5.10
P/E Ratio 11.44
Div & Yield 2.00 (3.13%)

CVS Has a Rare Stumble

Stocks on Hold as America Votes; Valeant Pharmaceuticals Shares Sink

Stocks on Hold as America Votes; Valeant Pharmaceuticals Shares Sink

U.S. stocks wavered Tuesday as America headed to the polls in a closely-watched presidential election between Hillary Clinton and Donald Trump.

Markets Await Tuesday's Presidential Election

Markets Await Tuesday's Presidential Election

Investors are bracing for Tuesday's all-important U.S. presidential election between Hillary Clinton and Donald Trump.

Jim Cramer: CVS Needs to Shed Its Image as a Health Care Stock

Jim Cramer: CVS Needs to Shed Its Image as a Health Care Stock

CVS needs to change its image to move ahead, says TheStreet's Jim Cramer.

Cramer: 9 Stocks to Watch if We Get a Midday Lull

Cramer: 9 Stocks to Watch if We Get a Midday Lull

Avoid stocks with poor numbers that would suffer under a Clinton administration.

How Do the Charts Look for Jim Cramer's Weekly Shopping List? Part 2

How Do the Charts Look for Jim Cramer's Weekly Shopping List? Part 2

Let's take a closer look at CVS Health and Valeant Pharmaceuticals.

What to Watch This Week: Presidential Election, Mylan Earnings

What to Watch This Week: Presidential Election, Mylan Earnings

For the week of November 7, all eyes will be on Tuesday's presidential election.

CVS Health: Positives May Take a While to Kick In

CVS Health: Positives May Take a While to Kick In

The stock is likely to drift lower before buyers feel good about it again.

Jim Cramer Explains Why Health Care Stocks are Getting Slammed on Wall Street Today

Jim Cramer Explains Why Health Care Stocks are Getting Slammed on Wall Street Today

McKesson's disappointing earnings report ignited a selloff in health care stocks, and Jim Cramer says investors are questioning the sector's future.

Cramer: Best Buy Could Pull Up These Retail Names

Cramer: Best Buy Could Pull Up These Retail Names

This group has become ridiculously cheap, but no one cares; watch Best Buy and TJX.

These Dogs Are Becoming Cool Cats

These Dogs Are Becoming Cool Cats

The dreck of the first half will be the gems of year end.

Don't Lump Target With Retail's Also-Rans

Don't Lump Target With Retail's Also-Rans

This year hasn't gone Target's way, but its smaller-store format is one way it quietly is working to build a competitive edge for the long haul.

Alphabet Steps Up Its Smartphone Game to Take On Apple

Alphabet Steps Up Its Smartphone Game to Take On Apple

Action Alerts PLUS holdings are preparing for a smartphone showdown, while fellow holding Walgreens could see a boost to earnings.

CVS Health numbers cut at Leerink

These Dogs May Soon Have Their Day

These Dogs May Soon Have Their Day

Problems have hit some favorite names, but opportunities are becoming apparent.

Will e.l.f. Beauty Be a Thing of Beauty Post-IPO?

Will e.l.f. Beauty Be a Thing of Beauty Post-IPO?

The stock has gotten off to a rousing start, but competition in the cosmetics space should cause investors to look below the surface.

ELF Beauty Thinks Its Customers Have A Bottomless Makeup Bag

ELF Beauty Thinks Its Customers Have A Bottomless Makeup Bag

ELF Beauty is now officially a public company. Here is what the company's CEO has planned to keep the company's results looking sexy.

CVS May Be Ailing, but That's Good

CVS May Be Ailing, but That's Good

The recent selloff doesn't track the strong economics of the business.

CVS: A Good Name, But Is It a Good Price?

CVS: A Good Name, But Is It a Good Price?

It doesn't seem a stretch to think CVS could rebound to $100 or better over the coming 12 months.

Ignore the Political Debate and Buy These 4 Cheap Pharma Stocks

Ignore the Political Debate and Buy These 4 Cheap Pharma Stocks

McKesson is down 10 percent year-to-date due to the heated political debate over drug pricing but the stock is too cheap to ignore.

Target: Expect More, Pay Less for Its Stock

Target: Expect More, Pay Less for Its Stock

The retailer's recent price weakness is an opportunity for investors to act.

CVS Has a Prescription for Profit

CVS Has a Prescription for Profit

The stock has the potential for a breakout move.

Cramer: Retail's too Strong to Keep Whining

Cramer: Retail's too Strong to Keep Whining

Mall and brick-and-mortar stores can still shine.

Cramer: Target's Excuses Really Don't Cut It

Cramer: Target's Excuses Really Don't Cut It

This was the quarter of bricks-and-mortar retail -- just not Target's bricks and mortar.

3 Stocks With Income and Upside Despite Market's New Highs

3 Stocks With Income and Upside Despite Market's New Highs

Becton Dickinson, CVS and General Dynamics offer value even after the recent run-up in stocks.

AAP Portfolio Cites Occidental's 'Discipline, Flexibility'

AAP Portfolio Cites Occidental's 'Discipline, Flexibility'

Company earnings in line while revenues miss in 'beleaguered oil environment.'

Trending Tickers: MNK, FTR, DISCA, CVS

Trending Tickers: MNK, FTR, DISCA, CVS

Markets were falling as oil prices continued their two-month descent below $40 a barrel.

Midday Report: Ford, GM Disappoints in July; U.S. Stocks Slide

Midday Report: Ford, GM Disappoints in July; U.S. Stocks Slide

U.S. stocks extended losses as auto sales in July disappointed, a rare miss after months of blowout growth.

CVS Health Looks Ready to Lose Support

CVS Health Looks Ready to Lose Support

This stock is not looking healthy when it comes to the charts.